Product Information
MINOCYCLINE 75 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.4054 per EA under NDC 65862021001. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 11, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Minocycline Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
75 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862021001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MINOCYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065470FDA Approved
3/11/2008
TE Code
AB
On Market Since
3/11/2008
Pharmacological Classes
Price Statistics
The NADAC for MINOCYCLINE 75 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 42.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4054 per EA |
|---|---|
| All-time high | $0.5390 (May 16, 2018) |
| All-time low | $0.2623 (Aug 20, 2014) |
| 52-week high | $0.4410 |
| 52-week low | $0.4004 |
| Median price | $0.4066 |
| Average price | $0.3998 |
| Largest weekly change | +42.7% (Jan 21, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MINOCYCLINE 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MINOCYCLINE 75 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.4054 per EA (NDC 65862021001), effective Aug 19, 2026.
How has the price of MINOCYCLINE 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MINOCYCLINE 75 MG CAPSULE has risen 42.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MINOCYCLINE 75 MG CAPSULE?
Since Nov 28, 2013, the NADAC for MINOCYCLINE 75 MG CAPSULE has ranged from a low of $0.2623 (Aug 20, 2014) to a high of $0.5390 (May 16, 2018), with a median of $0.4066 per EA.
Are there cheaper alternatives to MINOCYCLINE 75 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MINOCYCLINE 75 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures MINOCYCLINE 75 MG CAPSULE?
MINOCYCLINE 75 MG CAPSULE (NDC 65862021001) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.